The board members and volunteers of ESME would like to inform you that we will be closing ESME (the European Society for ME) before the end of 2012. ESME’s website will be accessible for approximately 1 year, but no new information will be added. The donations that were given to ESME will be given to a project to test Rituximab, as we believe this project has the potential to benefit all ME patients.
Press release by ME-DenHaag for political petition for recognizing ME, 27 jan 2012
By Dr G. Broderick, JOurnal of Internal Medicine, January 2012
By J. W. M. van der Meer, A. R. Lloyd, Journal of internal Medicine, January 2012
You can print this out for your doctor, family, friends and more.
Norwegian and english translations of articles and video`s from TV2. With a lot of thanks to TV 2, Norway, they did a wonderful job.
Two oncologists in the city of Bergen in Norway have recently discovered a possible treatment for Chronic Fatigue Syndrome. The drug that they administered improved the condition of two out of three of the patients treated. Several patients were healed.
The Health Directorate now say they are sorry that the services has not been good enough. " I think it is right to say that we have not developed good enough health services for those, and that I apologize for, says Guldvog."
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study.
ESME.com is designed, developed and hosted by Norsk Kunde & Medlemsutvikling